Ken Griffin
INDV icon

Ken Griffin’s Indivior Pharmaceuticals INDV Stock Holding History

Ken Griffin’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109M Buy
3,574,044
+512,142
+17% +$16.9M 0.02% 755
2025
Q4 		$110M Buy
3,061,902
+441,579
+17% +$13.5M 0.02% 794
2025
Q3 		$63.2M Buy
2,620,323
+2,599,177
+12,292% +$54.4M 0.01% 1176
2025
Q2 		$312K Sell
21,146
-48,483
-70% -$565K ﹤0.01% 9728
2025
Q1 		$664K Sell
69,629
-381,167
-85% -$4.01M ﹤0.01% 7840
2024
Q4 		$5.6M Buy
450,796
+138,211
+44% +$1.42M ﹤0.01% 3773
2024
Q3 		$3.05M Buy
312,585
+235,748
+307% +$2.76M ﹤0.01% 4749
2024
Q2 		$1.24M Sell
76,837
-12,558
-14% -$227K ﹤0.01% 6184
2024
Q1 		$1.91M Buy
+89,395
New +$1.68M ﹤0.01% 5610

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ken Griffin's INDV Position: Q1 2026 in Review

Ken Griffin increased its Indivior Pharmaceuticals (INDV) stake by 17% in Q1 2026, buying an estimated $16.9M and bringing the position to 3,574,044 shares worth $109M. The position accounts for 0.02% of the portfolio, ranked #755.

Ken Griffin first reported a position in INDV in Q1 2024 and has held it in 9 quarters since. The position peaked at $110M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Ken Griffin held 3,574,044 shares of Indivior Pharmaceuticals worth $109M as of Q1 2026.
  • Ken Griffin bought 512,142 Indivior Pharmaceuticals shares in Q1 2026, an estimated $16.9M.
  • Indivior Pharmaceuticals made up 0.02% of Ken Griffin's portfolio in Q1 2026, its #755 holding.
  • Ken Griffin first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Ken Griffin's Indivior Pharmaceuticals position peaked at $110M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.